Biomarker For Hyposialylation Disorders
US Application 61/785,094
Filed on 2013-03-14
Filed on 2013-03-14
Methods For Treating Progeroid Laminopathies Using Oligonucleotide Analogues Targeting Human Lamin A (LMNA)
US Application 61/568,590
Filed on 2011-12-08
Filed on 2011-12-08
Synthetic Methylmalonyl-CoA Mutase Transgene For The Treatment Of Mut Class Methylmalonic Acidemia (MMA)
US Application 61/792,081
Filed on 2013-03-15
Filed on 2013-03-15
Recurrent Mutation In Mitogen-Activated Protein Kinase Kinase Kinase 5 (MAP3K5) For Diagnosing And Treating Melanoma
US Application 61/708,785
Filed on 2012-10-02
Filed on 2012-10-02
Silent Mutation In Bcl-2-Like Protein 12 (BCL2L12) For Diagnosing and Treating Melanoma
US Application 61/673,454
Filed on 2012-07-19
Filed on 2012-07-19
Encapsulated N-acetyl-mannosamine (ManNAc) And N-acetylneuraminic Acid (NANA Or Neu5Ac) To Increase Sialylation
US Application 61/531,934
Filed on 2011-09-07
Filed on 2011-09-07
Anti-Cancer Therapy Sensitivity-Related ATAD5 Activity and Products and Methods Related Thereto
US Application 61/515,773
Filed on 2011-08-05
Filed on 2011-08-05
ACSF3 Mutations in Metabolic Disorders7/1/2012
US Application 61/504,030
Filed on 2011-07-01
Filed on 2011-07-01
METHODS FOR DETECTING ADHD SUSCEPTIBILITY AND PREDICTING SEVERITY AND LONG TERM OUTCOME OF ADHD SYMPTOMS
US Application 61/505,864
Filed on 2011-07-08
Filed on 2011-07-08
Method of Treating Pathologic Heterotopic Ossification (HO)
US Application 61/504,041
Filed on 2011-07-01
Filed on 2011-07-01